Andalib, A <br/><br/>
Determinants of masked hypertension in hypertensive patients treated in a primary care setting.  [electronic resource] 

 -  Internal medicine journal  Mar 2012 
 - 260-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1445-5994 
<br/><br/><label>Standard No.: </label>10.1111/j.1445-5994.2010.02407.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--administration & dosage<br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Antihypertensive Agents--administration & dosage<br/>Blood Pressure Monitoring, Ambulatory<br/>Cardiovascular Diseases--epidemiology<br/>Comorbidity<br/>Diabetes Complications--epidemiology<br/>Drug Therapy, Combination<br/>Dyslipidemias--epidemiology<br/>Female<br/>Heart Failure--epidemiology<br/>Humans<br/>Hydrochlorothiazide--administration & dosage<br/>Hypertension--drug therapy<br/>Male<br/>Masked Hypertension--epidemiology<br/>Middle Aged<br/>Obesity--epidemiology<br/>Prevalence<br/>Primary Health Care<br/>Quebec--epidemiology<br/>Risk<br/>Tetrazoles--administration & dosage<br/>Valine--administration & dosage<br/>Valsartan<br/>White Coat Hypertension--epidemiology